Anastrozole 1mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 1mg
Reference Brands: Arimidex (US/EU)
Category: Oncology Cancer Care
Anastrozole is a medicine used to treat breast cancer in women who have gone through menopause. It adjusts the level of sex hormone (estrogen) to treat early cases of breast cancer and helps in slowing down the growth of cancer cells, that need estrogen to grow.
Manufacture or export Anastrozole? List it or send an offer →
Product Description:
Anastrozole is a non-steroidal aromatase inhibitor. In postmenopausal women the ovaries no longer make oestrogen, but the aromatase enzyme in fat, muscle and breast tissue converts adrenal androgens into it, and that residual oestrogen drives hormone receptor-positive breast cancer. Anastrozole blocks aromatase reversibly and suppresses circulating oestrogen by more than ninety percent.
It is used as adjuvant treatment for early hormone receptor-positive breast cancer in postmenopausal women, and for advanced disease. It has largely replaced tamoxifen in this population, having shown better disease-free survival and fewer endometrial cancers and thromboembolic events — though with a different toxicity profile. The trade-off is skeletal and musculoskeletal: oestrogen deprivation accelerates bone loss, so bone density is monitored and bisphosphonates are often added, and arthralgia affects a large minority and is the commonest reason for stopping. It is ineffective in premenopausal women, whose ovaries simply increase output in response.
Sourcing notes. Long off patent, inexpensive, with many manufacturers — a commodity tablet where tender price decides. On essential medicines lists. A high-volume product because adjuvant treatment runs for five to ten years per patient.
Anastrozole — third party manufacturing & bulk supply
Anastrozole 1mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Anastrozole is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Anastrozole listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Anastrozole →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Related Products
Aprepitant
Strength:
80 mg, 125 mg capsules
Form: Capsules
Reference Brands: Emend (US/EU)
View DetailsAzacitidine Tablet
Strength:
200 mg, 300 mg
Form: Tablets
Reference Brands: Onureg (USA)
View DetailsBendamustine Hydrochloride
Strength:
25 mg, 100 mg vials
Form: Injection
Reference Brands: Treanda, Bendeka (US), Ribomustin (EU)
View DetailsLinvoseltamab-Gcpt
Strength:
5 mg/2.5 mL
Form: Injection
Reference Brands: Lynozyfic (USA/EU)
View DetailsTrametinib
Strength:
0.5 mg, 1 mg, 2 mg
Form: Tablets
Reference Brands: Mekinist (USA/EU)
View DetailsMercaptopurine
Strength:
50 mg
Form: Tablets / Oral suspension
Reference Brands: Purinethol (USA), Purixan (USA)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit